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Abstract 
  
Ethnopharmacological relevance: Aqueous extracts of Cymbopogon citratus (Cy) leaves are used in 
traditional medicine for the treatment of inflammatory conditions, however little is known about their 
mechanism of action. 
Aim of the study:  The aim of this study is to explore the anti-inflammatory properties of Cymbopogon 
citratus leaves and their polyphenol-rich fractions (PFs), as well its mechanism of action in murine 
macrophages. 
Materials and Methods: A lipid- and essential oil-free infusion of Cy leaves was prepared (Cy extract) 
and fractionated by column chromatography. Anti-inflammatory properties of Cy extract (1.115 mg/ml) 
and its PFs, namely phenolic acids (530 µg/ml), flavonoids (97.5 µg/ml) and tannins (78 µg/ml), were 
investigated using lipopolysaccharide (LPS)-stimulated Raw 264.7 macrophages as in vitro model. As 
inflammatory parameters, nitric oxide (NO) production was evaluated by Griess reaction, as well as 
effects on cyclooxygenase (COX-2), inducible NO synthase (iNOS) expression and on intracellular 
signaling pathways activation, which were analyzed by Western blot using specific antibodies. 
Results: Cy extract inhibited iNOS expression, NO production  and various LPS-induced pathways like 
p38 mitogen-activated protein kinase (MAPK), c-jun NH2-terminal kinase (JNK) 1/2 and the transcription 
nuclear factor (NF)-κB. The extracellular signal-regulated kinase (ERK) 1/2 and the phosphatidylinositol-
3-kinase (PI3K)/Akt activation were not affected by Cy extract. Both phenolic acid- and tannin-rich 
fractions significantly inhibited NF-κB activation, iNOS expression and NO production but none of the 
PFs modulated MAPKs or PI3K/Akt activation. Neither Cy extract or PFs affected LPS-induced COX-2 
expression but LPS-induced PGE2 production is inhibited by Cy extract and by phenolic acid-rich 
fraction. 
Conclusions: Our data provide evidence that support the usage of Cymbopogon citratus leaves extract in 
traditional medicine, and suggest that Cy, in particular its polyphenolic compounds, could constitute a 
natural source of a new and safe anti-inflammatory drugs.  
 
Keywords: Cymbopogon citratus, Poaceae-Gramineae, polyphenol, inflammation, nitric oxide, mitogen-
activated protein kinases, nuclear factor-κB 
 
Abbreviations: Cy, Cymbopogon citratus; COX, cyclooxygenase; ERK, extracellular signal-regulated 
kinase; FF, flavonoid-rich fraction; FSDC, fetal skin-derived dendritic cell; HPLC, high-performance 
liquid chromatography; Iκκ, IκB kinase; IκB, inhibitory protein κB; JNK, c-jun NH2-terminal kinase; 
LPS, lipopolysaccharide; MAPK, mitogen-activated protein kinase; MTT, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide; NF-κB, nuclear factor-κB; NO, nitric oxide; NOS, nitric oxide 
synthase; PAF, phenolic acid-rich fraction; PFs, polyphenol-rich fractions; PGE2, prostaglandin E2; PI3K, 
phosphatidylinositol-3-kinase; SNAP, S-nitroso-N-acetylpenicillamine; TF, tannin-rich fraction; TLC, 
thin layer chromatography;  
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1. Introduction 
 
Chronic inflammation is one of the leading causes of mortality in the western world and is associated 
with several pathologies like cancer (Porta et al., 2009), rheumatoid arthritis, diabesity (Schmidt and 
Duncan, 2003), cardiovascular and neurodegenerative diseases (Hunter and Doddi, 2010; Whitney et al., 
2009). However, the current anti-inflammatory drugs have several limitations such as lack of 
responsiveness, side effects, delivery problems and cost of manufacture. Therefore, there is an urgent 
need to find new anti-inflammatory agents with selective pharmacology and less toxicity. Plant extracts 
have been used for centuries in traditional medicine to alleviate inflammatory diseases, however, and for 
some of them, little is known about their mechanisms of action. The understanding of molecular 
mechanisms behind the healing properties of natural products is crucial to find compounds that could be 
useful as templates to new therapeutic molecules. Indeed, most of the drugs actually available are derived 
from natural products (Newman and Cragg, 2007), therefore, the knowledge of phytochemicals molecular 
mechanisms became a good strategy in the search for new anti-inflammatory compounds. 
In the inflammatory process, macrophages have a key role in providing an immediate defense against 
foreign agents. Upon activation with an inflammatory stimulus, such as lipopolysaccharide (LPS), 
macrophages produce a variety of pro-inflammatory mediators, including prostaglandin E2 (PGE2) and 
nitric oxide (NO) (Geller and Billiar, 1998). PGE2 is synthesized by the rate limiting enzyme 
cyclooxygenase (COX), while NO is synthesized by nitric oxide synthase (NOS). Cyclooxygenase exists 
as two major isoforms (COX-1 and COX-2) and one variant (COX-3). While COX-1 is constitutively 
expressed in many tissues, COX-2 is an inducible enzyme expressed in the inflammatory-related cells, 
like macrophages, which produces large amounts of prostaglandins. In addition, LPS-activated 
macrophages also express transcriptionally inducible NOS (iNOS) that produces high amounts of NO 
from L-arginine. To date, three isoforms of NOS have been identified: endothelial NOS (eNOS), neuronal 
NOS (nNOS) and iNOS. The high-output of NO by iNOS contributes to the pathogenesis of septic shock 
and inflammatory diseases (Guzik et al., 2003; Zamora et al., 2000). Therefore, the selective inhibition of 
COX-2 and iNOS in macrophages is a useful strategy to screen new anti-inflammatory drugs. 
The expression of pro-inflammatory molecules is tightly regulated by several transcription factors 
and signaling pathways. Among these pathways, mitogen-activated proteins kinases (MAPKs) are 
signaling molecules that play critical roles in the regulation of cell growth, differentiation, cell 
survival/apoptosis and cellular response to cytokines and stress. The MAPKs pathways include p38 
MAPK (Han et al., 1994), c-jun NH2-terminal kinase (JNK) and extracellular signal-regulated kinase 
(ERK) (Davis, 1994), and they are involved on LPS-induced COX-2 and iNOS expression in 
macrophages (Chen et al., 1999; Chen and Wang, 1999; Tsatsanis et al., 2006). Accordingly, it has been 
demonstrated that MAPKs inhibitors suppress the expression of iNOS gene (Chen et al., 1999). Besides, 
the iNOS expression could also be modulated by phosphatidylinositol-3-kinase (PI3K)/Akt pathway (Salh 
et al., 1998), a serine/threonine kinase activated in response to certain growth factors and cytokines that 
provides a strong cell survival signal (Crawley et al., 1996; Gold et al., 1994). MAPKs and Akt also play 
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a critical role in the activation of nuclear factor (NF)-κB (Carter et al., 1999; Nakano et al., 1998). The 
NF-κB transcription factor regulates the expression of many genes involved in immune and inflammatory 
responses, including iNOS and COX-2 (Geller and Billiar, 1998). Many stimuli like LPS, cytokines and 
oxidants activate NF-κB through several signaling pathways that lead to the phosphorylation of inhibitory 
protein κB (IκB) by IκB kinase (Iκκ), which is a marker for ubiquitination and subsequent degradation by 
proteasome. IκB degradation unmasks the nuclear localization motif of NF-κB, which is rapidly 
translocated to the nucleus, where it activates the transcription of target genes. Therefore, the involvement 
of MAPKs, Akt and NF-κB in the regulation of inflammatory mediator’s synthesis makes them potential 
targets for novel anti-inflammatory therapeutics. 
Cymbopogon citratus (DC) Stapf (Cy), Poaceae-Gramineae, commonly known as lemongrass, is a 
spontaneous perennial grass, largely distributed around the world, especially in tropical and subtropical 
countries. Its leaf essential oil citral is used in the food, perfumery, soap, cosmetic, pharmaceutical and 
insecticide industries (Negrelle and Gomes, 2007). Aqueous extracts of dried leaves are used in 
traditional medicine for the treatment of inflammation, digestive disorders, diabetes, nervous disorders, 
and fever, as well as other health problems (Carbajal et al., 1989; Lorenzetti et al., 1991). However, the 
mechanism of action of Cy is poorly explored and characterized, namely the mechanism responsible for 
its anti-inflammatory effects. We have previously demonstrated that Cy leaves extract has potent 
antioxidant activity that is related to its polyphenolic content (Figueirinha et al., 2008). In addition, we 
verified that this extract and its polyphenolic fractions inhibit LPS-induced NO production and iNOS 
expression in fetal skin-derived dendritic cell line (FSDC) (Figueirinha et al., 2010), reinforcing the 
potential use of Cy extract as source of a new anti-inflammatory drug. 
Thus, this study aimed to explore the anti-inflammatory properties of Cymbopogon citratus extract 
by addressing its molecular mechanism of action. For that, we evaluated the effect of a lipid- and essential 
oil-free infusion (extract) obtained from Cy leaves and its polyphenol-rich fractions in COX-2 and iNOS 
expression, NO production and activation of MAPKs, Akt and NF-κB signaling pathways in vitro. As an 
in vitro model of inflammation, we used the mouse macrophage cell line, Raw 264.7, stimulated with 
LPS from E. coli. 
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2. Materials and Methods 
 
2.1. Materials 
 
 LPS from Escherichia coli (serotype 026:B6) and the iNOS inhibitor, aminoguanidine, were 
obtained from Sigma Chemical Co. (St. Louis, MO, USA). Iscove´s Modified Dulbecco´s Medium, 
dexamethasone and wortmannin were from Sigma–Aldrich Química (Madrid, Spain). Fetal calf serum 
was purchased from Gibco (Paisley, UK). The protease and phosphatase inhibitor cocktails were obtained 
from Roche (Basel, Switzerland). SB203580, U0126, SP600125 and BAY 11-7082 were from 
Calbiochem (San Diego, CA, USA). Acrylamide was from Promega (Madison, WI, USA) and the 
polyvinylidene difluoride membranes were from Millipore Corporation (Bedford, MA). Antibodies 
against phospho-p44/p42 MAPK (ERK1/2), phospho-p38 MAPK, phospho-SAPK/JNK 1/2, phospho-Akt 
(Ser473) and IκB-α were from Cell Signaling Technologies (Danvers, MA, USA). The pan anti-JNK 
antibody was from R&D Systems (Minneapolis, MN, USA), the pan anti-p38 MAPK and Akt were from 
Cell Signaling Technologies (Danvers, MA, USA. The anti-actin and pan anti-ERK 1/2 antibodies were 
purchased from Millipore (Bedford, MA, USA). The alkaline phosphatase-linked secondary antibodies 
and the enhanced chemifluorescence reagent were obtained from GE Healthcare (Chalfont St. Giles, UK). 
All other reagents were from Sigma Chemical Co. (Saint Louis, MO) or from Merck (Darmstadt, 
Germany). 
 
2.2. Plant material and extract preparation  
 
Dry leaves of Cymbopogon citratus (Cy) Stapf. were purchased from ERVITAL® in July 2004 
and kept at -20ºC until be used. The plant was cultivated in the region of Mezio, Castro D´Aire 
(Portugal). A voucher specimen was deposited in the herbarium of the University of Coimbra, Faculty of 
Pharmacy and J. Paiva (Botany Department, University of Coimbra, Portugal) confirmed the identity of 
the plant. An infusion was prepared from the powdered plant material (1:30 w/v), treated with n-hexane 
to remove lipids and essential oils and then freeze-dried (Cy extract). A yield of 16.6±1.2 g / 100 g of dry 
plant was obtained. 
 
2.3. Extract fractionation 
 
 Cy extract was fractionated as previously described (Figueirinha et al., 2008) (Fig. 1). Briefly, 
the extract was treated with water and fractionated on a reverse phase semipreparative column 
Lichroprep® RP-18 (310 x 25 mm, particle sizes 40-63 μm), Merck (Darmstadt, Germany), eluted with 
water giving fraction F1 and with aqueous methanol solutions (fractions F2-F7). Dry residue of F7 was 
recovered in 50% aqueous ethanol and fractionated by gel chromatography on a Sephadex® LH-20 
(Sigma-Aldrich – Amersham, Sweden) column (85 x 2.5 cm) using ethanol as mobile phase. All the 
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fractionation process described above was monitored by high-performance liquid chromatography 
(HPLC) and thin layer chromatography (TLC) for polyphenols, providing three major fractions: tannin-
rich fraction (TF; yield of 3.5% (w/w) of Cy extract) corresponding to F6, flavonoid-rich fraction (FF; 
yield of 4.4%(w/w) of Cy extract) corresponding to sub-fraction F7a, and phenolic acid-rich fraction 
(PAF; yield of 23.8% (w/w) of Cy extract) corresponding to F2 and sub-fraction F7b, as described in 
Figueirinha et al. (2010). The fractions were then taken to dryness under reduced pressure (40 ºC). The 
Cy extract and the polyphenol-rich fractions were weighted in sterilized and humidity-controlled 
conditions, and then solubilized in endotoxin-free water. 
 
 
 
 
Fig. 1. Fractionation scheme of Cymbopogon citratus (Cy) extract. Aqueous solution was fractionated 
on a reverse phase semi-preparative Lichroprep® RP-18 (310 x 25 mm, particle sizes 40-63 μm) and 
Sephadex® LH-20 (85 x 2.5 cm) columns, providing three major fractions: phenolic acid-rich fraction 
(PAF), flavonoid-rich fraction (FF), and tannin-rich fraction (TF). 
 
 
2.4. Cell culture 
  
Raw 264.7, a mouse leukaemic monocyte macrophage cell line from American Type Culture 
Collection, and kindly supplied by Dr. Otília Vieira (Centro de Neurociências e Biologia Celular, 
Universidade de Coimbra, Coimbra, Portugal), were cultured in Iscove´s Modified Dulbecco’s Eagle 
Medium supplemented with 10% non-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml 
streptomycin at 37 °C in a humidified atmosphere of 95% air and 5% CO2. Along the experiments, cells 
were monitored by microscope observation in order to detect any morphological change. 
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2.5. Determination of cell viability by MTT assay 
 
 Assessment of metabolically active cells was performed using 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) reduction colorimetric assay as previously reported (Mosmann, 
1983). Raw 264.7 cells (6x10
5 
cells/well) were plated and allowed to stabilize for 12 h. Following this 
period, cells were either maintained in culture medium (control) or pre-incubated with Cy extract, its 
polyphenolic fractions or with inhibitors for 1 h, and later activated with 1 µg/ml LPS for 24 h. After the 
treatments, a MTT solution (5 mg/ml in phosphate buffered saline) was added and cells incubated at 37 
ºC for 15 min, in a humidified atmosphere of 95% air and 5% CO2.  Supernatants were then removed and 
dark blue crystals of formazan solubilized with acidic isopropanol (0.04 N HCl in isopropanol). 
Quantification of formazan was performed using an ELISA automatic microplate reader (SLT, Austria) at 
570 nm, with a reference wavelength of 620 nm. 
 
2.6. Measurement of nitrite production by Griess reagent 
 
The production of nitric oxide (NO) was measured by the accumulation of nitrite in the culture 
supernatants, using a colorimetric reaction with the Griess reagent (Green et al., 1982). Briefly, 170 µl of 
culture supernatants were diluted with equal volumes of the Griess reagent [0.1% (w/v) N-(1-naphthyl)-
ethylenediamine dihydrochloride and 1% (w/v) sulphanilamide containing 5% (w/v) H3PO4] and 
maintained during 30 min, in the dark. The absorbance at 550 nm was measured in an automated plate 
reader (SLT, Austria). Culture medium was used as blank and nitrite concentration was determined from 
a regression analysis using serial dilutions of sodium nitrite as standard. 
 
2.7. Determination of nitric oxide scavenging activity using S-nitroso-N-acetylpenicillamine (SNAP) as 
NO donor 
 
 The nitric oxide scavenging activity was evaluated by incubating 1.115 mg/ml Cy extract, 530 
μg/ml phenolic acid-rich fraction (PAF), 97.5 μg/ml flavonoid-rich fraction (FF), or 78 μg/ml tannin-rich 
fraction (TF) with 200 µM of NO donor SNAP, in culture medium during 3 h. After this period the nitrite 
levels in the medium were quantified by Griess method, as described above. 
 
2.8. Measurement of prostaglandin E2 (PGE2) by enzyme immunoassay (EIA) 
 
 To analyse the production of PGE2, Raw 264.7 cells (6x10
5
 cells/well) were plated and allowed 
to stabilize for 12 h. Following this period, cells were either maintained in culture medium (control) or 
pre-incubated with Cy extract or with its polyphenolic fractions, and later activated with 1 µg/ml LPS for 
24 h. After the treatments, the supernatants were collected and frozen at -80ºC until the assay was 
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performed. The PGE2 levels of diluted supernatants were quantified using an enzyme immunoassay (EIA) 
commercial kit from Cayman (Ann Arbor, MI, USA), following the manufacturer instructions. 
 
2.9. Western blot analysis 
  
 To prepare total cell lysates for Western blot analysis, Raw 264.7 cells (24x10
5 
cells/well) were 
plated and allowed to stabilize for 12 h. Following this period, cells were either maintained in culture 
medium (control) or pre-incubated with Cy extract and its polyphenolic fractions for 1 h and then 1 µg/ml 
LPS was added for the indicated time. Cells were lysed with RIPA buffer (50 mM Tris-HCl, pH 8.0, 1% 
Nonidet P-40, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate and 2 mM 
ethylenediamine tetraacetic acid) freshly supplemented with 1 mM dithiothreitol, protease and 
phosphatase inhibitor cocktails and sonicated (four times for 4 s at 40 μm peak to peak) in Vibra Cell 
sonicator (Sonics & Material INC.) to decrease viscosity. The nuclei and the insoluble cell debris were 
removed by centrifugation at 4ºC, at 12,000g for 10 min. The postnuclear extracts were collected and 
used as total cell lysates. Protein concentration was determined by the bicinchoninic acid protein assay 
and cell lysates were denaturated in sample buffer (0.125 mM Tris pH 6.8, 2% (w/v) sodium dodecyl 
sulfate, 100 mM dithiothreitol, 10% glycerol and bromophenol blue). 
 Western blot analysis was performed to evaluate the levels of iNOS and COX-2, and the 
activation of MAPKs, Akt and NF-κB signaling pathways. Briefly, equivalent amounts of protein were 
separated by 10% (v/v) SDS-PAGE followed by Western blotting. To examine the different proteins 
studied, the blots were incubated overnight at 4 ºC with the respective primary antibodies: COX-2 
(1:10000), iNOS (1:7500), phospho-p38 MAPK (1:1000), phospho-JNK1/2 (1:1000), phospho-ERK 1/2 
(1:1000), phospho-Akt (1:500) and total IκB (1:1000). Protein detection was performed using the 
enhanced chemifluorescence system and the membranes were scanned for blue excited fluorescence on 
the Storm 860 (GE Healthcare). The generated signals were analyzed using the software ImageQuant 
TL®. To demonstrate equivalent protein loading, membranes were stripped and reprobed with antibodies 
against the total form of MAPKs and Akt or with anti-actin antibody.  
 
2.10. Statistical analysis 
 
Results are expressed as mean±SEM of the indicated number of experiments. Statistical analysis 
comparing a treatment condition to control was performed between two groups and analyzed using two-
sided unpaired t-test. When comparing the effect of different treatments to LPS-stimulated cells, a 
multiple group comparison was performed and one-way ANOVA followed by Dunnett's test was used. 
The statistical tests were applied using GraphPad Prism, version 5.02 (GraphPad Software, San Diego, 
CA, USA). The significance level was 
#
p <0.05, 
##
p <0.01 and 
##
p <0.001, when compared to control and 
*p <0.05, **p <0.01 and ***p <0.001, when compared to LPS. 
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3. Results 
 
3.1. Evaluation of the anti-inflammatory properties and molecular targets of lipid- and essential oil-
free Cymbopogon citratus leaves infusion (Cy extract) 
 
Some studies have been conducted with citral, the main volatile compound of the essential oil of 
Cymbopogon citratus (Cy) (Cheel et al., 2005; Lee et al., 2008), however little is known about the 
properties and mechanisms of action of the fixed compounds, namely polyphenols. Therefore, in the 
present study we analyzed their anti-inflammatory potential and evaluated some molecular targets of 
these extracts in LPS-stimulated Raw 264.7 cells. The Cy extract concentration used for this study was 
selected based on our previous results, obtained in dendritic cells (Figueirinha et al., 2010), and also on 
the absence of macrophages toxicity (table 1). 
 
 
Table 1. Effect of Cy extract, polyphenol-rich fractions and signaling pathways inhibitors on 
macrophage cell viability. Raw 264.7 cells were treated with the indicated compounds for 24 h, and the 
cell viability was assessed as described in materials and methods. The results are expressed as percentage 
of control (non-treated cells) and each value represents the mean±SEM from at least 3 independent 
experiments. Statistical analysis was performed using one-way ANOVA followed by Dunnett's test. 
Condition 
Cell viability (% of control)  
mean±SEM 
   Control 100 
   Cy extract (1.115 mg/ml) 122.40±3.71 
   PAF (530 μg/ml) 82.24±3.95 
   FF (97.5 μg/ml) 84.69±4.09 
   TF (78 μg/ml) 89.33±5.80 
   LPS (1 µg/ml) 103.10±5.46 
   LPS + Cy (1.115 mg/ml) 112.00±5.59 
   LPS + PAF (530 μg/ml) 97.00±7.15 
   LPS + FF (97.5 μg/ml) 92.12±4.69 
   LPS + TF (78 μg/ml) 93.74±5.73 
   LPS + Dexamethasone (20 µM) 96.97±12.21 
   LPS + SB203580 (20 µM) 93.96±9.08 
   LPS + SP600125 (20 µM) 95.58±8.35 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
 
10 
 
   LPS + U0126 (10 µM) 89.68±7.77 
   LPS + Wortmannin (500 nM) 86.06±11.37 
   LPS + BAY 11-7083 (250 nM) 101.20±5.88 
   LPS + Aminoguanidine (50 µM) 95.18±8.21 
 
 
3.1.1. Cy extract does not affect LPS-induced COX-2 expression but inhibits the PGE2 production 
 
We analyzed the effect of Cy extract on LPS-induced COX-2 expression after 24 h of murine 
macrophages stimulation by Western blot using a specific anti-COX-2 antibody (Fig. 2A). In non-
stimulated Raw 264.7 cells (control), COX-2 protein was almost undetectable, but after LPS treatment the 
expression strongly increased to 10573±1544% of control (p<0.001). The LPS-induced COX-2 
expression was not significantly inhibited by Cy extract (7824±1489% of control) while the extract alone 
was able to induce the expression of COX-2 (3226±579% of control).  
Instead Cy did not inhibit the LPS-induced COX-2 expression, the enzyme activity could be 
compromised. Therefore, we next investigated the effect of Cy extract on a product of COX-2 activity, 
PGE2, by enzyme immunoassay (EIA). As shown in Fig. 2B, the cell treatment with LPS induced a great 
increase in PGE2 production, consistent with the results obtained for COX-2 expression, which is 
inhibited by macrophage pre-treatment with Cy (42.40% of inhibition). The Cy alone increased the LPS-
induced PGE2 production comparing to untreated Raw 264.7 cells (from 0.71±0.16 of control to 
7.56±0.29 of Cy). Taken together, these results indicated that Cy extract did not inhibit the LPS-induced 
COX-2 activity, but modulates its activity, exhibiting anti-inflammatory properties, while the extract 
alone increased the COX-2 expression and the PGE2 production. 
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Fig 2. Lack of effect of Cymbopogon citratus (Cy) extract on LPS-induced COX-2 expression and 
inhibition of LPS-induced PGE2 production in murine macrophages. (A) Raw 264.7 cells (24x10
5
 
cells) were maintained in culture medium (control), or pre-incubated with 1.115 mg/ml Cy extract for 1 h 
and then treated with 1 µg/ml LPS for 24 h. COX-2 expression was analyzed by Western blot using a 
specific anti-COX-2 antibody. An anti-actin antibody was used to confirm equal protein loading. The blot 
shown is representative of 3 blots yielding similar results. Results were expressed as percentage of COX-
2 protein levels relatively to control. (B) Raw 264.7 cells (6x10
5
 cells) were maintained in culture 
medium (control), or pre-incubated with 1.115 mg/ml Cy extract for 1 h and then treated with 1 µg/ml 
LPS for 24 h. PGE2 levels were evaluated in the culture supernatants by enzyme immunoassay (EIA), as 
described in material and methods, and the results expressed as percentage of LPS.  Each value represents 
the mean±SEM from 2-3 independent experiments (
###
p<0.001, compared to control; **p<0.01, compared 
to LPS). 
 
 
3.1.2. Cy extract inhibits LPS-induced iNOS expression and nitrite production 
  
We also investigated the effect of Cy extract on the production of the pro-inflammatory mediator 
NO, found in inflammatory disorders (Guzik et al., 2003). First, the effect of Cy in iNOS expression 
triggered by LPS was verified by Western blot (Fig. 3A). In untreated cells (control), iNOS protein 
expression is not detected but after treatment with LPS for 24 h, iNOS expression is strongly increased 
(1841±121.4% of control), as described earlier (Thiemermann, 1997).  Pre-treatment of cells with Cy 
extract reduced the LPS-induced expression by 28.95% while extract alone slightly increased the iNOS 
expression (491.7±53.67% of control).    
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Secondly, the effect on NO production was analyzed by measuring accumulation of nitrite in the 
culture medium. As shown in Fig. 3B, untreated Raw 264.7 cells produced low levels of nitrites 
(2.115±0.7590 μM), consistent with the data obtained for iNOS expression in resting conditions. After 
cell activation with LPS for 24 h, the nitrite production increased to 46.67±2.623 μM, while macrophage 
pre-treatment with Cy strongly decreased the LPS-induced nitrite production (64.07% of inhibition). The 
Cy alone slightly increased nitrite production (10.59±1.691 µM). To evaluate Cy anti-inflammatory 
potency, a comparison with the known anti-inflammatory compound dexamethasone was performed. A 
decrease on LPS-induced NO production by Cy extract was verified in a magnitude similar to that 
observed for 20 µM dexamethasone (64.07% and 79.56%, respectively). We also analyzed the NO 
scavenging capacity of Cy extract, using SNAP as NO donor, and we found that Cy extract was no NO 
scavenging properties (data not shown). Taken together, these results suggest that Cy extract exhibit anti-
inflammatory properties by inhibiting LPS-induced NO production while the extract slightly promoted 
NO production. 
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Fig 3. Inhibitory effect of Cymbopogon citratus (Cy) extract on LPS-induced iNOS protein 
expression and nitrite production in murine macrophages. (A) Raw 264.7 cells (24x10
5
 cells) were 
maintained in culture medium (control), or pre-incubated with 1.115 mg/ml Cy extract for 1 h and then 
treated with 1 µg/ml LPS for 24 h. iNOS expression was analyzed by Western blot using a specific anti-
iNOS antibody and an anti-actin antibody was used to confirm equal protein loading. The blot shown is 
representative of 3 blots yielding similar results. Results were expressed as percentage of iNOS protein 
levels relatively to control. (B) Raw 264.7 cells (6x10
5
 cells) were maintained in culture medium 
(control), or pre-incubated with 1.115 mg/ml Cy extract or 20 μM dexamethasone for 1 h and then treated 
with 1 µg/ml LPS for 24 h. Nitrite levels in the culture supernatants were evaluated by the Griess reaction 
as described in material and methods. Nitrite concentration was determined from a sodium nitrite standard 
curve and the results are expressed as concentration (μM) of nitrite in culture medium. Each value 
represents the mean±SEM from at least 3 experiments (
###
p<0.001, compared to control; *p <0.05, 
***p<0.001, compared to LPS). 
 
At last, the signaling pathways involved in the modulation of NO production were investigated 
using specific inhibitors. The concentrations of these inhibitors were chosen based on the absence of 
citotoxicity to macrophages (table 1).  As shown in Fig. 4, the LPS-induced nitrite production was 
inhibited by SB203580 (53.59% of inhibition), a specific inhibitor of p38 MAPK, by SP600125 (65.40% 
of inhibition), a selective and reversible JNK inhibitor, by BAY 11-7082 (67.80% of inhibition), a NF-κB 
inhibitor, and by aminoguanidine (79.42% of inhibition), an inhibitor of iNOS. Both ERK 1/2 inhibitor 
(U0126) and PI3K/Akt inhibitor (wortmannin) were without effect on nitrite production.  
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Fig 4. Evaluation of signaling pathways involved in the modulation of nitrite production on LPS-
stimulated macrophages. Raw 264.7 cells (6x10
5
 cells) were maintained in culture medium (control), or 
pre-incubated with the indicated inhibitors (20 μM SB203580 as p38 MAPK inhibitor, 20 μM SP600125 
as JNK inhibitor, 10 μM U0126 as ERK inhibitor, 500 nM Wortmannin as PI3K/Akt inhibitor, 250 nM 
BAY 11-7082 as NF-κB inhibitor and 500 μM Aminoguanidine as iNOS inhibitor) and then 1 µg/ml LPS 
was added for 24 h. Nitrite levels in the culture supernatants were evaluated by the Griess reaction as 
described in materials and methods. Nitrite concentration was determined from a sodium nitrite standard 
curve and the results are expressed as concentration (μM) of nitrite in culture medium. Each value 
represents the mean±SEM from at least 3 experiments (
###
p<0.001, compared to control; ***p<0.001, 
compared to LPS). 
 
 
3.1.3. Cy extract inhibits LPS-induced activation of p38 MAPK, JNK 1/2 and NF-κB 
  
 Our results demonstrated that LPS-induced NO production in macrophages was inhibited by Cy 
extract and regulated by p38 MAPK, JNK 1/2 and NF-κB signaling pathways but not by ERK 1/2 or 
PI3K/Akt. Therefore, we next evaluated the effect of Cy extract on the activation of those pathways by 
Western blot using phospho-specific antibodies. As shown in Fig. 5, LPS stimulation for 30 min induced 
the phosphorylation of Akt and all MAPKs, namely p38 MAPK, JNK 1/2 and ERK 1/2, as described 
previously (Rao, 2001). Pre-treatment with 1.115 mg/ml Cy extract inhibited the LPS-induced 
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phosphorylation of p38 MAPK and JNK 1/2 but had no effect in the activation of ERK 1/2 and Akt 
pathways. When added to control cells, Cy alone stimulated both MAPKs and Akt signaling pathways. 
Since NF-κB transcription factor is a crucial player in the inflammatory process by controlling 
the expression of several pro-inflammatory genes, such as iNOS, an investigation of how NF-κB 
activation is affected by the Cy extract in LPS-activated macrophages was carried out measuring IκBα 
proteolytic degradation by Western blot. After 15 min of macrophages stimulation with LPS, we observed 
that IκBα was almost completely degradated (Fig. 5E). Pre-treatment of 1 h with 1.115 mg/ml Cy extract 
partially prevented the IκBα degradation induced by LPS and therefore the NF-κB activation.  Taken 
together these data suggest that Cy extract selectively inhibits different LPS-induced pro-inflammatory 
signaling cascades. 
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Fig 5. Inhibitory effect of Cymbopogon citratus (Cy) extract on the LPS-activation of p38 MAPK, 
JNK 1/2 and NF-κB signaling pathways. Raw 264.7 cells (24x105 cells) were maintained in culture 
medium (control), or pre-incubated with 1.115 mg/ml Cy extract for 1 h and then treated with 1 μg/ml 
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LPS for 30 min to see the effect on MAPKs and Akt phosphorylation or for 15 min to see the effect on 
IκBα degradation. Total cell extracts were analyzed by Western blot using antibodies against (A) 
phospho-p38 MAPK, p38 MAPK, (B) phospho-JNK 1/2, JNK 1/2, (C) phospho-ERK 1/2, ERK 1/2, (D) 
phospho-Akt, Akt, (E) IκBα and actin. Each blot shown is representative of 3 blots yielding similar 
results. 
 
 
3.2. Contribution of polyphenolic fractions, namely phenolic acid-, flavonoid- and tannin-rich 
fractions of Cymbopogon citratus leaves infusion to the Cy extract activity 
 
 Cy polyphenolic fractions inhibited the LPS-induced NO production and iNOS expression in 
dendritic cells (Figueirinha et al., 2010). So, we next evaluated the contribution of each polyphenolic 
fraction, namely phenolic acids (PAF) flavonoids (FF) and tannins (TF), to the effect of Cy extract in 
LPS-stimulated macrophages. The concentrations of the fractions used in this work were selected based 
on the absence of citotoxicity (table 1) and their ratios in the Cy extract after the fractionation: PAF 
(23.8%), FF (4.4%) and TF (3.5%).  
  
3.2.1. Cy polyphenolic fractions do not affect COX-2 expression, but PAF inhibits PGE2 production 
 
First, we tested the effect of polyphenol-rich fractions in the LPS-induced COX-2 expression in 
Raw 264.7 macrophages. Similarly to the Cy extract, none of the fractions tested, PAF (530 μg/ml), FF 
(97.5 μg/ml) and TF (78 μg/ml), affected the macrophage COX-2 expression elicited by LPS (Fig. 6A).  
Since Cy extract inhibited the PGE2 production in LPS-stimulated macrophages, we next 
investigated the contribution of polyphenolic fractions to this activity. As shown in figure 6B, the LPS-
induced PGE2 production is strongly inhibited by PAF (35.17±2.47% of LPS), but not significantly 
affected by FF or TF (106.20±3.50% and 79.54±0.36% of LPS, respectively). These results indicated that 
PAF is partially responsible for the anti-inflammatory properties of Cy extract by inhibition of PGE2 
production. 
The effect of Cy fractions on COX-2 expression and PGE2 production in non-stimulated cells 
was also tested and none of the treatments interfered neither with the COX-2 expression either with PGE2 
production. 
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Fig 6. Lack of effect of polyphenol-rich fractions from Cy on LPS-induced COX-2 expression and 
inhibition of LPS-induced PGE2 production by PAF in macrophages. (A) Raw 264.7 cells (24x10
5
 
cells) were maintained in culture medium (control), or pre-incubated for 1 h with 530 μg/ml phenolic 
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acid-rich fraction (PAF), or 97.5 μg/ml flavonoid-rich fraction (FF), or 78 μg/ml tannin-rich fraction (TF) 
and then treated with 1 µg/ml LPS for 24 h. Total cell extracts were analyzed by Western blot using a 
specific anti-COX-2 antibody and an anti-actin antibody was used to confirm equal protein loading. The 
blot shown is representative of 3 blots yielding similar results. Results were expressed as percentage of 
COX-2 protein levels relatively to control. (B) Raw 264.7 cells (6x10
5
 cells) were treated as above. PGE2 
levels were evaluated in the culture supernatants by enzyme immunoassay (EIA), as described in material 
and methods, and the results expressed as percentage of LPS.  Each value represents the mean±SEM from 
2-3 independent experiments (
###
p<0.001, compared to control; *** p<0.001, compared to LPS). 
 
 
3.2.2. Polyphenol-rich fractions inhibit LPS-induced iNOS expression and NO production 
  
Since Cy extract inhibited iNOS expression and NO production in LPS-stimulated Raw 264.7 
macrophages, the contribution of polyphenol-rich fractions to this activity was investigated. All fractions 
drastically decreased the expression of iNOS (Fig. 7A) and this inhibition was higher than that observed 
for the whole extract. PAF inhibited the LPS-induced iNOS expression by 75.37%, FF by 75.73% and TF 
by 86.34%, while Cy extract inhibited the iNOS expression by 28.95% (Fig. 3A). In addition, PAF and 
TF fractions significantly inhibited the LPS-induced nitrite production by 50.63% and 41.59%, 
respectively (Fig. 7B). Similarly to Cy extract, none of the fractions exhibit NO scavenging properties 
(data not shown). From these results, we can conclude that these fractions highly contribute to the anti-
inflammatory properties of Cy extract. To note that, the fractions alone did not increase iNOS expression 
nor NO production, suggesting that polyphenolic compounds are not responsible for the slight pro-
inflammatory properties observed with the Cy extract. 
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Fig 7. Inhibitory effect of polyphenol-rich fractions from Cy on LPS-induced iNOS expression and 
nitrite production. (A) Raw 264.7 cells (24x10
5
 cells) were maintained in culture medium (control), or 
pre-incubated for 1 h with 530 μg/ml phenolic acid-rich fraction (PAF), or 97.5 μg/ml flavonoid-rich 
fraction (FF), or 78 μg/ml tannin-rich fraction (TF) and then treated with 1 µg/ml LPS for 24 h. Total cell 
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extracts were analyzed by Western blot using an anti-iNOS antibody and an anti-actin antibody was used 
to confirm equal protein loading. The blot shown is representative of 3 blots yielding similar results. 
Results were expressed as percentage of iNOS protein levels relatively to control. (B) Raw 264.7 cells 
(6x10
5
 cells) were treated as above. Nitrite levels in the culture supernatants were evaluated by the Griess 
reaction as described in material and methods. Nitrite concentration was determined from a sodium nitrite 
standard curve and the results are expressed as concentration (μM) of nitrite in culture medium. Each 
value represents the mean±SEM from at least 3 experiments (
###
p<0.001, compared to control; 
***p<0.001, compared to LPS). 
 
 
3.2.3. Polyphenol-rich fractions inhibit LPS-mediated NF-κB activation but not MAPKs or PI3K/Akt 
signaling pathways 
 
 As Cy extract inhibited the LPS-induced p38 MAPK and JNK 1/2 activation, the contribution of 
polyphenol-rich fractions to the signaling pathways modulated by Cy was analyzed. As shown in Fig. 8, 
the polyphenol-rich fractions did not interfere significantly with the LPS-induced activation of MAPKs 
and Akt pathways, but inhibited the LPS-induced IκBα degradation. Overall, these results indicate that 
the polyphenolic fractions of Cymbopogon citratus are not responsible for the modulation of p38 MAPK 
and JNK 1/2; however they seem to be involved in the inhibition of LPS-induced NF-κB activation. 
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Fig 8. Inhibitory effect of polyphenol-rich fractions from Cy on LPS-activation of NF-κB signaling 
pathway. Raw 264.7 cells (24x10
5
 cells) were maintained in culture medium (control), or pre-incubated 
for 1 h with 530 μg/ml phenolic acid-rich fraction (PAF), or 97.5 μg/ml flavonoid-rich fraction (FF), or 
78 μg/ml tannin-rich fraction (TF) and then treated with 1 μg/ml LPS for 30 min to see the effect on 
MAPKs and Akt phosphorylation or for 15 min to see the effect on IκBα degradation. Total cell extracts 
were analyzed by Western blot using antibodies against (A) phospho-p38 MAPK, p38 MAPK, (B) 
phospho-JNK 1/2, JNK 1/2, (C) phospho-ERK 1/2, ERK 1/2, (D) phospho-Akt, Akt, (E) IκBα and actin. 
Each blot shown is representative of 3 blots yielding similar results. 
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4. Discussion 
 
 In the course of screening anti-inflammatory compounds derived from plants, we previously 
demonstrated that Cymbopogon citratus (Cy) has strong antioxidant properties due to the presence of 
polyphenols (Figueirinha et al., 2008) and that Cy extract inhibits NO production and iNOS expression in 
dendritic cells (Figueirinha et al., 2010), suggesting an anti-inflammatory activity for this plant. The 
present study demonstrates that Cy extract, used in traditional medicine to treat inflammation and other 
health problems (Carbajal et al., 1989; Lorenzetti et al., 1991), has anti-inflammatory properties due to 
the selective inhibition of NO production through the pro-inflammatory signaling cascades p38 MAPK, 
JNK 1/2 and NF-κB, in murine macrophages. 
Using LPS-stimulated macrophages as in vitro model, we demonstrated that Cy extract inhibited 
iNOS expression and NO production. Using pharmacological signaling pathways inhibitors, it was 
observed that the LPS-induced NO production is mainly controlled by p38 MAPK, JNK 1/2 and NF-κB 
pathways. Accordingly, previous studies demonstrated that JNK 1/2 (Zhou et al., 2008) and p38 MAPK, 
but not ERK 1/2 (Chen and Wang, 1999), modulated iNOS expression and NO production in LPS-
stimulated Raw 264.7 macrophages. In addition, activated MAPKs and PI3K/Akt were also implicated in 
NF-κB activation (Carter et al., 1999; Nakano et al., 1998), being NF-κB one of the critical transcription 
factors that controls iNOS gene expression in macrophages (Geller and Billiar, 1998). Cy extract also 
inhibited p38 MAPK, JNK 1/2 and NF-κB signaling pathways. Therefore, and since the signaling 
pathways involved in NO production are the same that Cy extract inhibited, the inhibition of NF-κB, p38 
MAPK and JNK 1/2 pathways by Cy extract is probably  responsible for its inhibitory effect on NO 
production. It was also observed that the iNOS inhibitor aminoguanidine almost abolished the nitrite 
production induced by LPS, indicating that in Raw 264.7 macrophages stimulated with LPS, the iNOS 
protein is the main, if not the only, NO producer. The effect of Cy extract on NO production was quite 
similar to that of the iNOS inhibitor aminoguanidine, emphasizing its potent anti-inflammatory capacity 
and indicating that Cy extract inhibited NO production in part by inhibiting the iNOS expression. 
However, taking into account the higher effect in NO production relatively to the effect on iNOS 
expression, the Cy extract may also affect the levels of NO by other mechanisms. It was previously 
demonstrated that Cy extract had strong antioxidant properties (Cheel et al., 2005; Orrego et al., 2009), 
however we observed that Cy extract did not possess NO scavenging activity. Therefore, probably it 
affected the NO levels by other mechanisms than its antioxidant properties. 
 Cy extract has a high content in polyphenolic compounds (Figueirinha et al., 2008) that are 
secondary metabolites of plants with many healthy effects, including anti-inflammatory properties 
(Gonzalez-Gallego et al., 2007). Besides its antioxidant properties, recent data suggest that polyphenols 
could have other anti-inflammatory action mechanisms, namely, inhibition of iNOS, COX-2, MAPKs and 
NF-κB pathways  and that the inhibitory mechanisms of polyphenols are not only signal specific, but also 
cell type dependent (Santangelo et al., 2007). Analyzing the effect of the polyphenol-rich fractions on 
iNOS expression and NO production we conclude that PAF and TF are the fractions responsible for the 
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inhibitory effect on NO production observed with the Cy extract. Probably, these fractions have a 
synergistic effect since the Cy extract has a little more activity than each fraction. Moreover, the 
polyphenolic fractions have a stronger inhibitory effect on iNOS expression. All the fractions inhibited 
iNOS expression while only PAF and TF inhibited NO production, suggesting that polyphenolic fractions 
modulate not only the iNOS expression but also its activity. Accordingly, recent studies demonstrate that 
polyphenols could modify the iNOS activity by modulating the availability of L-arginine, the rate-
limiting substrate of iNOS (Mori and Gotoh, 2000). We also previously demonstrated that Cy extract and 
its polyphenols have iNOS and NO inhibitory properties in dendritic cells (Figueirinha et al., 2010). 
However, the polyphenol-rich fractions have different inhibitory capacity in dendritic and macrophage 
cells, indicating that the action of Cy polyphenols might be cell specific.  
Many evidences reported that MAPKs signaling cascades might be differentially involved in the 
macrophage response to anti-inflammatory compounds (Choi et al., 2008; Lee et al., 2010; Park et al., 
2008; Zhou et al., 2008). In order to explore the mechanisms underlying the inhibitory effect of 
polyphenol-rich fractions on NO production, phosphorylation levels of p38 MAPK, JNK 1/2, ERK 1/2 
and Akt were analyzed by Western blot in LPS-stimulated Raw 264.7 macrophages. In contrast to Cy 
extract, none of the polyphenolic fractions inhibited MAPKs or PI3K/Akt pathways indicating that 
polyphenols are not involved in the inhibition of these pathways, being the compounds responsible for 
these effects eliminated during the fractionating procedure. Furthermore, we also observed that 
polyphenolic fractions inhibited the LPS-induced IκB degradation, suggesting that the inhibitory effect of 
the fractions on LPS-induced iNOS expression is due to inhibition of NF-κB activation, as described for 
other compounds (Cheng et al., 2001; Pan et al., 2000). Since NF-κB has an important role in 
inflammation and its inhibition is one of the main strategies to alleviate chronic inflammation, we can 
conclude that Cy extract, in particular their polyphenol-rich fractions, are a promising source of new anti-
inflammatory drugs. In agreement, we are actually conducting more detailed work to better understand 
the modulation of NF-κB by Cy extract and to identify the compounds responsible for this effect, using 
bioguided assays. 
In the present study it was showed that Cy extract inhibited PGE2 production, being phenolic 
acid-rich fraction (PAF) responsible by this activity. However, neither Cy extract nor its polyphenolic 
fractions seemed to inhibit the LPS-induced COX-2 expression. Current treatment of inflammation is 
mainly based in non-steroid anti-inflammatory drugs (NSAIDs) that act by inhibiting COX-2. However, 
recent investigation points out that COX-2 specific inhibitors are associated with adverse renal and 
cardiovascular effects (Harirforoosh and Jamali, 2009; Ritter et al., 2009). Since  FF and TF did not 
inhibit COX-2 expression neither its activity, they could be used as anti-inflammatory agents avoiding the 
secondary effects associated with COX-2 inhibition. 
Intriguingly, Cy extract alone has a stimulatory effect, slightly increasing iNOS expression and 
NO production. This effect was due to the intrinsic properties of the extract and not due to the presence of 
endotoxins, since we obtained the same increase on NO production after application of the Cy extract in a 
endotoxin removal column (data not shown). However, in the LPS-stimulated macrophages the anti-
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inflammatory properties of Cy overlay its pro-inflammatory activity, occurring inhibition of iNOS 
expression and NO production, as well as inhibition of p38 MAPK, JNK 1/2 and NF-κB activation, all 
these events being straightly connected with inflammation. In addition, the polyphenol-rich fractions did 
not show stimulatory effects and did not interfere with signaling pathways, indicating that the compounds 
responsible for the pro-inflammatory properties of the Cy extract are not the polyphenols contained in 
those fractions.  
In conclusion, this paper demonstrates that a lipid- and essential oil-free infusion of 
Cymbopogon citratus leaves strongly inhibited the iNOS expression, NO production, p38 MAPK, JNK 
1/2 and NF-κB signaling pathways in murine macrophages (Fig. 9), being the phenolic acids (PAF) and 
tannins (TF) responsible for its anti-inflammatory properties through inhibition of transcription factor NF-
κB, iNOS expression and NO production. Taken together, these results provide evidence to understand 
the therapeutical effects of Cy extract, and suggest that its polyphenols might be a potential natural source 
of new anti-inflammatory drugs for the treatment of inflammatory disorders. However, further work is 
required to identify which compound(s) are responsible for the anti-inflammatory properties of 
Cymbopogon citratus, as well as the cellular and molecular mechanisms underlying these properties. 
 
  
 
 
Fig 9. Schematic model for the anti-inflammatory mechanism of lipid- and essential oil-free 
infusion of Cymbopogon citratus leaves (Cy extract) and its polyphenol-rich fractions on LPS-
stimulated murine macrophages. 
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Table 1. Effect of Cy extract, polyphenol-rich fractions and signaling pathways inhibitors on 
macrophage cell viability. Raw 264.7 cells were treated with the indicated compounds for 24 h, and the 
cell viability was assessed as described in materials and methods. The results are expressed as percentage 
of control (non-treated cells) and each value represents the mean±SEM from at least 3 independent 
experiments. Statistical analysis was performed using one-way ANOVA followed by Dunnett's test. 
Condition 
Cell viability (% of control)  
mean±SEM 
   Control 100 
   Cy extract (1.115 mg/ml) 122.40±3.71 
   PAF (530 μg/ml) 82.24±3.95 
   FF (97.5 μg/ml) 84.69±4.09 
   TF (78 μg/ml) 89.33±5.80 
   LPS (1 µg/ml) 103.10±5.46 
   LPS + Cy (1.115 mg/ml) 112.00±5.59 
   LPS + PAF (530 μg/ml) 97.00±7.15 
   LPS + FF (97.5 μg/ml) 92.12±4.69 
   LPS + TF (78 μg/ml) 93.74±5.73 
   LPS + Dexamethasone (20 µM) 96.97±12.21 
   LPS + SB203580 (20 µM) 93.96±9.08 
   LPS + SP600125 (20 µM) 95.58±8.35 
   LPS + U0126 (10 µM) 89.68±7.77 
   LPS + Wortmannin (500 nM) 86.06±11.37 
   LPS + BAY 11-7083 (250 nM) 101.20±5.88 
   LPS + Aminoguanidine (50 µM) 95.18±8.21 
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